Streetbeat News

Earnings

BAK

Braskem reported its Q3 financial results, leading to an increase in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:38 pm

DYNT

Dynatronics reported Q1 losses of $(0.12) per share, beating the analyst consensus estimate of $(0.23) by 47.83%. The company also reported quarterly sales of $9.35 million, beating the analyst consensus estimate of $9.12 million by 2.54%. However, this represents a 22.41% decrease over sales of $12.05 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:38 pm

EVOK

Evoke Pharma reported Q3 losses of $(0.51) per share, beating the analyst consensus estimate of $(0.62) by 17.74%. This is a 15% increase over losses from the same period last year. The company also reported quarterly sales of $1.56 million, beating the analyst consensus estimate of $1.26 million by 24.05%. This is an 87.84% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:38 pm

ELY

Topgolf Callaway reported mixed Q3 financial results and issued Q4 revenue guidance below estimates. The company also lowered its FY23 EPS and revenue guidance below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:37 pm

VIRX

Viracta Therapeutics reported Q3 losses of $(0.33) per share, missing the analyst consensus estimate of $(0.30) by 10 percent. However, this is a 29.79 percent improvement over losses of $(0.47) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:37 pm

IRON

Disc Medicine (NASDAQ:IRON) reported Q3 losses of $(0.58) per share, beating the analyst consensus estimate of $(0.80) by 27.5 percent.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:37 pm

SCSC

ScanSource has projected its FY24 revenue to be at least $3.8 billion, which is slightly below the estimated $3.88 billion.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:36 pm

EVOK

Evoke Pharma (NASDAQ:EVOK) reported Q3 earnings, beating estimated earnings by 17.74% with an EPS of $-0.51 versus an estimate of $-0.62. Revenue was up $730 thousand from the same period last year. Last quarter, the company beat on EPS by $0.17, which was followed by a 3.55% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 1:35 pm

RL

Ralph Lauren Corporation (NYSE:RL) reported a 3% YoY sales growth to $1.63 billion for Q2 FY24, beating the analyst consensus estimate of $1.61 billion. The company's adjusted EPS of $2.10 also surpassed the consensus estimate of $1.93. Ralph Lauren's current dividend yield is 2.58%, equating to a quarterly dividend of 75 cents a share ($3.00 a year). To earn $500 monthly from Ralph Lauren dividends, an investor would need to own approximately $232,940 worth of Ralph Lauren, or 2,000 shares.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 1:34 pm

MGM

MGM Resorts reported better-than-expected Q3 financial results and announced a $2 billion share repurchase plan, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:34 pm